閉塞性動脈疾患(Occlusive Arterial Disease (OAD)):治療薬のグローバル治験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables4
List of Figures 5
Introduction 6
Occlusive Arterial Disease (OAD) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Occlusive Arterial Disease (OAD) to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Occlusive Arterial Disease (OAD) to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Occlusive Arterial Disease (OAD) 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Occlusive Arterial Disease (OAD) Therapeutics Clinical Trials 33
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Sanofi 35
Clinical Trial Overview of Sanofi 35
AstraZeneca PLC 37
Clinical Trial Overview of AstraZeneca PLC 37
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
AnGes MG, Inc. 40
Clinical Trial Overview of AnGes MG, Inc. 40
Merck & Co., Inc. 41
Clinical Trial Overview of Merck & Co., Inc. 41
Cytokinetics, Inc. 42
Clinical Trial Overview of Cytokinetics, Inc. 42
ZonMw 43
Clinical Trial Overview of ZonMw 43
Nissan Chemical Industries, Ltd. 44
Clinical Trial Overview of Nissan Chemical Industries, Ltd. 44
F. Hoffmann-La Roche Ltd. 45
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 45
ARCA biopharma, Inc. 46
Clinical Trial Overview of ARCA biopharma, Inc. 46
Clinical Trial Overview of Top Institutes / Government 47
National Heart, Lung, and Blood Institute 47
Clinical Trial Overview of National Heart, Lung, and Blood Institute 47
University Hospital, Angers 48
Clinical Trial Overview of University Hospital, Angers 48
Northwestern University 49
Clinical Trial Overview of Northwestern University 49
Medical University of Vienna 50
Clinical Trial Overview of Medical University of Vienna 50
Kokura Memorial Hospital 51
Clinical Trial Overview of Kokura Memorial Hospital 51
Nagoya University 52
Clinical Trial Overview of Nagoya University 52
Department of Health, South Africa 53
Clinical Trial Overview of Department of Health, South Africa 53
University of California, San Francisco 54
Clinical Trial Overview of University of California, San Francisco 54
Duke University 55
Clinical Trial Overview of Duke University 55
University of Virginia 56
Clinical Trial Overview of University of Virginia 56
Five Key Clinical Profiles 57
Appendix 83
Abbreviations 83
Definitions 83
Research Methodology 84
Secondary Research 84
About GlobalData 85
Contact Us 85
Disclaimer 85
Source 85


【レポート販売概要】

■ タイトル:閉塞性動脈疾患(Occlusive Arterial Disease (OAD)):治療薬のグローバル治験動向(2014年下半期)
■ 英文:Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014
■ 発行日:2014年9月21日
■ 調査会社:GlobalData
■ 商品コード:GDHC2344CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。